TI is Rockin': The Retro Tech Wizard's Magic!

Discover how Texas Instruments blends legacy tech, innovation, and big CHIPS Act wins to stay profitable and power the semiconductor world.

In partnership with

Just as Texas Instruments has thrived through strategic investments, you too can diversify your portfolio by exploring opportunities like Klondike Royalties' energy assets in Alaska.

Add a piece of the energy sector to your portfolio.

  • Access to 300 million barrels of recoverable oil reserves

  • Royalty-based investment model reducing operational risks

  • Projected 25+ years of potential royalty income

Have you ever wondered how a company founded in the 1930s could still be at the forefront of cutting-edge tech?

Meet Texas Instruments (NASDAQ: TXN), the OG innovator in semiconductors.

With nearly a century of adapting, innovating, and staying ahead, TI continues to prove that old-school can still be cool—and wildly profitable.

Thanks to strategic investments and hefty CHIPS Act funding, the company is revamping its manufacturing game.

For investors, this means opportunities (and a few challenges) worth exploring.

TI’s Core Business: The Building Blocks of Modern Tech

TXN’s Financial Breakdown from Gurufocus

Texas Instruments’ empire is built on two main pillars: Analog and Embedded Processing.

Analog: Think of power management chips that keep your smartphone and EVs alive, or signal chain products that help devices "sense" their environment.

TI’s analog components are everywhere.

Embedded Processing: This segment delivers microcontrollers (tiny brains for devices), digital signal processors (DSPs for heavy lifting), and application-specific processors for niche tasks.

Here’s the kicker: TI’s vertical integration strategy sets it apart.

By controlling most of its manufacturing, the company keeps costs low, quality high, and supply chains resilient.

Plus, their focus on mature tech nodes (28nm to 130nm) keeps production both efficient and reliable.

Translation? Consistent profits and a rock-solid competitive edge.

Solid Numbers in a Wobbly Market

TXN’s Chart from StockCharts.com

TI’s stock has grown over 22% in the past year, and its financials mostly deliver good vibes.

While Q3 FY2024 revenue hit $4.15 billion (just beating expectations), it was still 8% lower than last year due to weak industrial demand.

But here’s the silver lining: EPS soared to $1.47, crushing estimates of $1.38.

Plus, with a juicy trailing EPS of $5.38 and a return on equity (ROE) of 29.05%, TI continues to flex its profitability muscles.

The caveat? A lofty P/E ratio of 35.56 might give some investors pause.

The CHIPS Act: A Game-Changer?

The CHIPS and Science Act is a big win for TI, with direct funding of $1.6 billion and tax credits between $6 billion and $8 billion.

These funds will supercharge their 300mm wafer fabrication facilities in Texas and Utah, boosting production and domestic manufacturing.

But not so fast—execution matters.

Delays, cost overruns, or demand fluctuations could dent profitability.

For now, though, it’s a promising tailwind.

Dividends: Sweet but Risky

TXN’s Payment Growth from Simply Wall Street

Texas Instruments has raised its dividend for 21 consecutive years.

Currently offering $5.44 annually (a 2.86% yield), it’s an income investor’s dream.

But there’s a red flag: the dividend payout ratio exceeds 100% of trailing earnings.

While cash flow keeps it sustainable short term, long-term investors should keep an eye on this potential vulnerability.

Market Confidence (and Caution)

If Texas Instruments can innovate for decades, imagine the possibilities with Cizzle Bio’s cutting-edge advancements in cancer detection. Check it out now!

Lung cancer is the deadliest cancer worldwide.

Cizzle Biotech’s 95% accurate early detection blood test identifies lung cancer at the most treatable stage. Support our patented solution to improve survival rates.

Read the Offering information carefully before investing. It contains details of the issuer’s business, risks, charges, expenses, and other information, which should be considered before investing. Obtain a Form C and Offering Memorandum at invest.cizzlebio.com

Institutional investors hold 85% of TI shares, signaling strong confidence.

Analyst opinions, however, are mixed.

Some are bullish with price targets up to $298, while others recommend holding or even selling.

This reflects the challenges and opportunities in TI’s evolving strategy.

Risks: Not All Sunshine and Semiconductors

Investing in TI isn’t without risks.

Cyclicality: Demand for semiconductors ebbs and flows with economic conditions.

Competition: Rivals constantly push TI to innovate.

Global Issues: Geopolitical instability and supply chain disruptions remain wildcards.

Smart investors should weigh these risks carefully before jumping in.

Final Thoughts: Is TI a Buy?

Texas Instruments offers a unique mix of legacy stability and forward-thinking growth.

Its leadership in analog and embedded processing, solid financials, and commitment to shareholder returns make it a strong contender for long-term portfolios.

But remember—high dividend payouts and industry headwinds require a cautious approach.

As always, do your homework and assess your risk tolerance.

Your Turn to Act!

What do you think about TI’s approach to the CHIPS Act funding?

Do you see dividends as a strength or a red flag?

Let us know in the comments!

Share this post with fellow investors and start a discussion.

Join the Super Investor’s Club for exclusive insights and strategies: Super Investor’s Club.

Ready to up your game in options trading? Grab The Ultimate Options Strategy Guide: Ultimate Options Strategy Guide..

Love this content? Buy me a coffee to keep the ideas brewing: Buy Me a Coffee.

Code. Grow. Prosper.

Reply

or to participate.